EUVIMEDEUVIMED entdecken
Crossref

Qi‐dan‐dihuang decoction ameliorates renal fibrosis in diabetic rats via p38MAPK / AKT / mTOR signaling pathway

Liuyan Kuang, Yanting You, Jieying Qi, Jieyu Chen, Xinghong Zhou, Shuai Ji, Jingru Cheng, Hiu Yee Kwan, Pingping Jiang, Xiaomin Sun, Mengting Su, Ming Wang und 4 weitere

Environmental Toxicology · 2024-06 · 39 (6) · 3481-3499

DOI: 10.1002/tox.24179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 08.03.2024. Verfasst von Liuyan Kuang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Nephropathies, Drugs, Chinese Herbal, Signal Transduction. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, China, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, Science and Technical Plan of Guangzhou, Guangdong, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Qi‐dan‐dihuang decoction (QDD) has been used to treat diabetic kidney disease (DKD), but the underlying mechanisms are poorly understood.

Objective

This study reveals the mechanism by which QDD ameliorates DKD. Materials and Methods The compounds in QDD were identified by high‐performance liquid chromatography and quadrupole‐time‐of‐flight tandem mass spectrometry (HPLC‐Q‐TOF‐MS). Key targets and signaling pathways were screened through bioinformatics. Nondiabetic Lepr db/m mice were used as control group, while Lepr db/db mice were divided into model group, dapagliflozin group, 1% QDD‐low (QDD‐L), and 2% QDD‐high (QDD‐H) group. After 12 weeks of administration, 24 h urinary protein, serum creatinine, and blood urea nitrogen levels were detected. Kidney tissues damage and fibrosis were evaluated by pathological staining. In addition, 30 mmol/L glucose‐treated HK‐2 and NRK‐52E cells to induce DKD model. Cell activity and migration capacity as well as protein expression levels were evaluated.

Results

A total of 46 key target genes were identified. Functional enrichment analyses showed that key target genes were significantly enriched in the phosphatidylinositol 3‐kinase (PI3K)/protein kinase B (AKT) and mitogen‐activated protein kinase (MAPK) signaling pathways. In addition, in vivo and in vitro experiments confirmed that QDD ameliorated renal fibrosis in diabetic mice by resolving inflammation and inhibiting the epithelial‐mesenchymal transition (EMT) via the p38MAPK and AKT‐mammalian target of rapamycin (mTOR) pathways. Discussion and Conclusion QDD inhibits EMT and the inflammatory response through the p38MAPK and AKT/mTOR signaling pathways, thereby playing a protective role in renal fibrosis in DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetic NephropathiesDrugs, Chinese HerbalSignal TransductionAnimalsHumansMaleMiceRatsCell LineFibrosisKidneyp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktRats, Sprague-DawleyTOR Serine-Threonine Kinases

Stichwörter der Autor:innen

Qi‐dan‐dihuang decoctiondiabetic kidney diseaseepithelial‐mesenchymal transitioninflammatory responsenetwork pharmacologyrenal fibrosis

Substanzen

Drugs, Chinese Herbalp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Endocrinology Department, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • School of Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • Taishan People's Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Taishan, Guangdong, China.
  • Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
  • Department of Traditional Chinese Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.

ORCID-Profile: Ren Luo

Förderung

  • Natural Science Foundation of Guangdong Province, China
  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
  • Science and Technical Plan of Guangzhou, Guangdong, China
  • Key Project of National Natural Science Foundation of China
  • National Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Kuang, L., You, Y., Qi, J., Chen, J., Zhou, X., Ji, S., Cheng, J., Kwan, H. Y., Jiang, P., Sun, X., Su, M., Wang, M., Chen, W., Luo, R., Zhao, X., & Zhou, L. (2024). Qi‐dan‐dihuang decoction ameliorates renal fibrosis in diabetic rats via p38MAPK / AKT / mTOR signaling pathway. Environmental Toxicology, 39(6), 3481-3499. https://doi.org/10.1002/tox.24179

Vancouver

Kuang L, You Y, Qi J, Chen J, Zhou X, Ji S, et al. Qi‐dan‐dihuang decoction ameliorates renal fibrosis in diabetic rats via p38MAPK / AKT / mTOR signaling pathway. Environmental Toxicology. 2024;39(6):3481-3499. doi:10.1002/tox.24179

BibTeX
@article{Kuang2024,
  author = {Kuang, Liuyan and You, Yanting and Qi, Jieying and Chen, Jieyu and Zhou, Xinghong and Ji, Shuai and Cheng, Jingru and Kwan, Hiu Yee and Jiang, Pingping and Sun, Xiaomin and Su, Mengting and Wang, Ming and Chen, Wenxiao and Luo, Ren and Zhao, Xiaoshan and Zhou, Lin},
  title = {Qi‐dan‐dihuang decoction ameliorates renal fibrosis in diabetic rats via p38MAPK / AKT / mTOR signaling pathway},
  journal = {Environmental Toxicology},
  year = {2024},
  volume = {39},
  number = {6},
  pages = {3481--3499},
  doi = {10.1002/tox.24179}
}
Kostenlos starten →